| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-15 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.34 | 2e-09 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.29 | 3e-08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.27 | 5e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.25 | 4e-06 |